qianlie huikang

Qianlie Huikang is a Traditional Chinese Medicine (TCM) formulation developed by Tonghua Tianli Pharmaceutical for the treatment of prostate-related conditions. It is primarily indicated for non-bacterial chronic prostatitis and benign prostatic hyperplasia (BPH), specifically targeting the damp-heat and blood stasis syndrome according to TCM principles. The drug is formulated as a tablet and has undergone clinical evaluation in China to assess its efficacy in improving urinary symptoms and reducing inflammation associated with chronic prostatitis. Clinical trials have included multi-center, randomized, double-blind, placebo-controlled studies to evaluate its safety and therapeutic benefit in patients presenting with typical TCM syndromes of the prostate.

Brand names

Qianlie Huikang

Other names

Qianlie Huikang Tablet前列回康片